Development and Efficacy of Metacognitive Intervention for Individuals With Severe Mental Disorders
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- University of Haifa
- Enrollment
- 84
- Primary Endpoint
- Positive and Negative Syndrome Scale
Study Overview
Brief Summary
The overall aim of this study was to develop a meta-cognitive group intervention in order to apply it and to understand and distinguish the components that influence participation among people with schizophrenia
Detailed Description
The overall aim of this study was to develop a Meta cognitive group intervention in order to apply it and to understand and distinguish the components that influence participation among people with schizophrenia. The specific objectives were to:
- Improve participation by increasing the effectiveness of cognitive strategy use and teaching clients to independently review performance and to examine the strategy's effectiveness.
- Compare the use of cognitive strategies between participants with schizophrenia and their matched controls following the Meta cognitive group intervention and to correlate the cognitive strategies use and participation following the Meta cognitive group.
- Examine whether symptoms moderate the association between metacognitive outcomes and participation among people with schizophrenia following the Meta cognitive group.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Treatment
- Masking
- Double (Investigator, Outcomes Assessor)
Eligibility Criteria
- Ages
- 23 Years to 68 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Confirmed diagnosis of schizophrenia by a licensed psychiatrist
- •Fluency in Hebrew
- •t-score of at least 65 on the Behavior Rating Inventory of Executive Function-Adult version
Exclusion Criteria
- •Severe psychiatric hospitalization of over 24 hours during the month prior to the beginning of the study
- •Used drugs or alcohol
Outcomes
Primary Outcomes
Positive and Negative Syndrome Scale
Time Frame: 15 minutes
The Positive and Negative Syndrome Scale is a 30-item scale with seven positive and seven negative symptoms items and 16 psychopathological items. The severity of each item is rated on a scale from 1 (none) to 7 (most severe). A general Positive and Negative Syndrome Scale score is between 30 (lack of symptoms) and 210 (very severe state of the disease). Potential ranges are 7 to 49 for the positive and negative symptom scales and from 16 to 12 for the general psychopathology scale.
Secondary Outcomes
No secondary outcomes reported
Investigators
Naomi Josman
Prof
University of Haifa